Delivery Order SPE2DB22D2006-SPE2DB24FV7WT
Award Date
2/1/24
Potential Completion Date
2/2/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $35,313.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a pharmaceutical product, with a completion date of February 10, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,655.94, is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S medication. The award is not associated with a set-aside program and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a pharmaceutical product. The contract has a ceiling value of $20,286.87 and is a Delivery Order awarded under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S tablets. The contract has a firm fixed price and a ceiling value of $31,058.35, with a performance period ending on January 31, 2025. The contract is not associated with any set-aside requirements. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) was issued to the prime contractor Amerisourcebergen Drug Corp for the delivery of TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, a pharmaceutical product. The contract has a total ceiling value of $5,362.48 and is structured as a firm fixed price delivery order with an ultimate completion date of January 8, 2025. The contract is not designated with any set-aside requirements. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a $102,846.18 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication, with a performance period through July 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of TELMISARTAN-HCTZ 80-25 MG TAB 30S, a pharmaceutical product. The contract has a ceiling value of $3,869.06 and is set to expire on July 19, 2024. AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The contract is a firm fixed-price delivery order and does not have a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,303.60, is a delivery order for TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has a period of performance through November 12, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $35,683.26, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a medical product used in the treatment of hypertension. The contract has an ultimate completion date of January 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,501.46, is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC...